Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Mounjaro, a newer medication, combines a GLP-1 receptor agonist with a glucose-dependent insulinotropic polypeptide (GIP) agonist, offering a dual-action approach to enhance weight loss and glycemic control
Beyond weight loss, GLP-1 medications are shown to improve blood sugar regulation, cardiovascular health markers, and metabolic function
If you have Crohn's disease and are considering weight management options, understanding your baseline inflammatory biomarkers and genetic predispositions in peptide pathways may help support a more informed discussion with your gastroenterologist
PlexusDx's $298 genetic test analyzes peptide-pathway variants (GIPR, FTO, MC4R) across 14 biological pathways and 150+ genetic insights
